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INTRODUCTION
Neuroendocrine (NE) tumor is a generic term de-
scribing any neoplasm with NE differentiation in the
vast majority of the tumor cells (1). According to the
World Health Organization (WHO) classification, these
“typical or pure”NE tumors arising in the gastroin-
testinal (GI) tract have been classified into well differ-
entiated NE tumors (WDNETs), well differentiated
NE carcinomas (WDNECs), and poorly differentiated
NE carcinomas (PDNECs) (2). In addition, a recent
systematic application of various modern techniques
to the pathologic study of GI tract tumors hasmade a
progressive recognition of frequent presence of NE
cells/components in the non-endocrine tumors. Mor-
phologic, ultrastructural and immunohistochemical
studies have shown that a continuous spectrum of GI
tract tumors exists, ranging from classical adenocarci-
nomas or adenomas at one end, through various types
of mixed exocrine-NE tumors, to typical NE tumors
on other end (3).
Gastric epithelial tumors composed of exocrine cells
and NE cells can be divided into two broad groups ;
1) adenoma or adenocarcinomawith interspersedNE
cells (4-6) and 2)mixed exocrine-NE tumors, inwhich
NE components represent at least one-third to half of
the tumor tissue, either intimately and diffusely ad-
mixed with the non-NE components termed“combined
tumors”or occurring in separate areas of the same
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tumors termed“composite tumors”(3). Lewin also clas-
sified mixed exocrine-NE tumors as 1) mixed (com-
posite) glandular-endocrine tumors, 2) amphicrine
tumors, and 3) collision tumors (1). Gastric compos-
ite NE-exocrine carcinomas (NEECs), where two
histologically different tissues, adenocarcinoma and
NE carcinoma, are found in juxtaposition to each other
in the same tumor, are rare (7-12) and our interest was
addressed in this type of tumors. The histogenesis
and biological behavior of composite NEECs are still
remaining unknown, but these tumors are unique be-
cause theymay have aclue for clarifying the pathogene-
sis of NE tumors arising from the non-endocrineorgans.
This study was done to characterize histological
features and NE properties of composite NEECs of
the stomach by use of immunohistochemistry, which
included neural cell adhesion molecule (NCAM) that
has been known to be expressed in NE tissues and
tumors and to have a potential role in tumorigenesis
of some tumors (13-15), ghrelin which is a novel pep-
tide in the stomachandhasbeenshown tobeexpressed
in well differentiatedNE tumors of theGI tract but not
in poorly differentiated NE carcinomas (16, 17), and
Smad4 (also known as DPC4) which has been known
to be involved in the tumorigenesis of adenocarci-
nomas and NE tumors of the pancreas and GI tract
(18 -22). We analyzed the expression of these sub-
stances in composite NEECs of the stomach and
pure NE tumors arising in the GI tract.
MATERIALS AND METHODS
1. Materials
From the register of surgical pathology files of
the Department of Human Pathology,TheUniversity of
Tokushima Graduate School and affiliated hospitals,
we surveyed for NE tumors arising from theGI tract.
Total 29 NE tumors were retrieved. In addition, we
included one case of composite NEEC arising in the
gallbladder because it had all the criteria of compos-
ite NEEC. All 30 tumors were fixed with 10% forma-
lin and embedded in paraffin immediately after re-
section. Four µm-thick sections were cut from each
block and mounted on glass slides. They were then
stained with hematoxylin and eosin and evaluated for
the histological classification of the lesions accord-
ing to the standard criteria of WHO classification (2).
NE tumors of the GI tract were divided into two
groups ; 1) composite NEECs : those tumors consisted
of both NE and adenocarcinoma components juxta-
posed within each individual tumor and the NE com-
ponents occupied at least 30% of the tumor tissue,
and 2) pureNE tumors : those tumors exclusively con-
sisted of NE tissues. Eight composite NEECs were
found and all of them were localized in the stomach
and 21 pure NE tumors were from various sites of
theGI tract. NE components of composite NEECs and
pure NE tumors in this study showed chromogranin
A (CgA)- and/or synaptophysin-immunoreactivity in
a substantial number of tumor cells (Fig. 1). Clinical
data were collected from the medical reports.
2. Immunohistochemistry
NCAM, ghrelin and Smad4 immunostainings were
performed based on the labeled streptavidin biotin
complex (LSAB)method by use of the LSABkit (Dako
Corp., Denmark). After deparaffinization and anti-
gen retrieval using the autoclave technique, the sections
were incubated at 4℃overnight with primary antibod-
ies : monoclonal antibodies for NCAM (CD56 ; clone
1B6 ; 1 : 50 dilution, Novocastra Lab., UK) and Smad4
(1 : 200 dilution, Santa Cruz Biotechnology, USA)
and goat polyclonal antibody of ghrelin that recognizes
the mid-portion of ghrelin (1 :200 dilution, Santa Cruz
Biotechnology). We had prepared for two other types
of ghrelin antibody in our study : ghrelin antibodies
that recognize eitherN-terminal or C-terminal of ghre-
lin (gifts of Prof. K. Kangawa, Department of Biochem-
istry, National Cardiovascular Center Research Insti-
tute, Japan). However, the ghrelin C-terminal antibody
gave the same positive reaction as the mid-portion
antibody in the mucosa of the stomach and colon/
rectum and the N-terminal antibody gave only a faint
reaction in our materials.
After incubation with the primary antibodies, bioti-
nylated link antibody and peroxidase-labeled strep-
Fig.1．Chromogranin A (CgA) immunostaining of composite
NEEC (Case1). Most tumor cells in NE component are immunore-
active for CgA at right side of the photograph and only a few CgA-
positive cells in adenocarcinoma component at left.
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tavidin were applied for 1 h each at room tempera-
ture. Sections were washed thoroughly in phosphate
buffer saline (PBS) between each of the procedures.
Antigen-antibody complex was detected using 3, 3′-
diaminobenzidine/H2O2 reaction. These slides were
counterstained lightly with hematoxylin and mounted
for microscopic examination.
We scored the immunoreactivity according to the
number of positive cells as well as the intensity of stain-
ing of each tumor cell. The number of positive cells
was scored as most (more than 50%), moderate (be-
tween 5% and 50%) and a few (less than 5%), respec-
tively. The intensity of immunoreactivity was indi-
cated by +++ (strong), ++ (intermediate), and + (faint),
respectively. Specificity for ghrelin antibodywas evalu-
ated by the absorption test using specific antigen (0.5-
5.0 µg in 1mLof diluted antiserum). NE cells of peritu-
moral oxyntic gastricmucosa served as positive (inter-
nal) control. Negative controls for NCAM and Smad4
were obtained by replacing the primary antibodies
by PBS solution.
3. Statistical analysis
The Fisher’s PLSD test was used to determine the
difference in variability level between the distributions
of two independent groups. Probability value p<0.05
was considered statistically significant.
RESULTS
1. Clinicopathological findings
Patients with composite NEECs of the stomach
were 7 men and 1 woman and the mean age of the
patients was 71 yr-old (range : 60-84 yr-old) (Table 1).
The tumor size was ranged from 2.0 to 8.0 cm in di-
ameter with a mean of 4.6 cm. On the other hand, pa-
tients with pure NE tumors were 14 men and 7 women
and the mean age of the patients was 57 yr-old (range :
34-82 yr-old)(Table2）. The tumor size ranged 0.4-4.0
cm in diameter with amean of 1.3 cm. Seventeen tumors
were less than 2.0 cm in diameter. Seven of 21 pure
NE tumors arose from the foregut, 3 from themidgut
and 11 from the hindgut.
2. Histological findings
Histologically, composite NEECs of the stomach
presented the population composed of different pro-
portion displaying a typical adenocarcinoma pattern
with glandular arrangement co-localized with areas
arranging in a trabecular and/or solid pattern suggest-
ing NE differentiation. In 5 (Cases 2-4, 6, 7) of 8 com-
posite NEECs, NE components weremuch larger than
adenocarcinoma components and infiltrated through
muscularis propia or beyond (Table 1 and Fig. 2). In
two cases (Cases 1, 8) smaller NE components were
observed. In one composite NEEC (Case 5) NE and
adenocarcinoma components were equal in size and
confined in the submucosa andmucosa, respectively.
Table 1. Clinicopathological characteristics of composite NEEC of stomach
No
Age
(yrs)
Sex
Size(cm)
Histology & tumor depth NE
adenocarcinoma
arrangement
Dominant
componentNE component
Adenocarcinoma
component
1 78 M 3.8 PDNEC(sm) WD-AD (sm) Within AD AD
2 74 M 5.2 PDNEC(se) WD-AD (sm) AD upon NE NE
3 73 M 2.4 PDNEC(se) WD-AD (sm) AD upon NE NE
4 84 M 2.0 PDNEC(mp) WD-AD (sm) AD upon NE NE
5 60 F 2.8 PDNEC(sm) WD-AD (sm) AD upon NE Even
6 62 M 8.0 PDNEC(se) MD-AD (m) AD upon NE NE
7 69 M 5.5 PDNEC(se) PD-AD (sm) AD upon NE NE
8 67 M 7.0 PDNEC(na) WD-AD (se) na AD
9＊ 89 F 1.6 PDNEC(mp) WD-AD (mp) AD upon NE NE
M : male, F : female. PDNEC : poorly differentiated neuroendocrine carcinoma,
WD : well differentiated, MD : moderately differentiated, PD : poorly differentiated, NE :
neuroendocrine, AD : adenocarcinoma, na : not available due to lack of tissue sample. sm :
submucosa, mp : muscularis propria, se : serosa.
＊Composite NEEC of gallbladder
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All 8 adenocarcinoma components were superficially
located and out of 8 adenocarcinoma components 7
cases confined in themucosa and submucosa and one
case (Cases 8) infiltrated through muscularis propia
or beyond (Fig. 2) (Table 1). Adenocarcinoma com-
ponents were well-differentiated type in most cases
(Fig. 3) except for 2 cases (Cases 6, 7), where mod-
erately and poorly differentiated adenocarcinomas
were found. NE components were mostly PDNECs
characterized by highly atypical, intermediate-sized
cells growing in ill-defined aggregates, oftenwith high
mitotic index (Fig. 3). Transitional zone between the
two components was observed in all 8 cases but not
prominent.
Tumor cells of pure NE tumorswere characterized
by granular or clear cytoplasm, round to ovoid nuclei
with small inconspicuous nucleoli, granular chromatin
and minimum to moderate pleomorphism. The cells
grew in nests, clusters or trabeculae, occasionally form-
ing tubular or pseudo-glandular structures (Fig. 4).
We divided the pure 21NE tumors into two categories,
WDNETs and WDNECs, on the basis of the size and
the depth of the tumor according to the WHO classi-
fication (2) (Table 2). There were 15 WDNETs and
6 WDNECs. In WDNETs mitoses was <2/10 high-
power-field (HPF), while WDNECs had a moderately
elevated mitotic index (>2/10 HPF).
Table 2. Clinicopathological and immunohistochemical finding of pure NE tumors of gastrointestinal tract
No
Age
(yrs)/ Sex
Location Histology
Size(cm)/
Invasion
NCAM Ghrelin Smad4
10 40 M Stomach WDNET 0.9/sm Many/++ Many/+++ Many/++
11 70 F Stomach WDNET 0.9/sm Few/+ Few/+++ Many/+++
12 46 M Stomach WDNET 1.0/sm － Moderate/++ Moderate/++
13 56 M Duodenum WDNET 1.3/sm Many/++ Many/+ Many/+++
14 64 M Duodenum WDNET 0.4/sm Moderate/++ Few/+ Many/++
15 66 M Duodenum WDNET 0.8/mp Many/+++ － Many/+++
16 63 F Appendix WDNET 0.4/sm Many/+++ Many/+++ Many/++
17 34 M Colon WDNET 0.6/sm Many/++ Many/+++ Many/+++
18 60 M Rectum WDNET 1.0/sm － Many/+++ Many/++
19 62 M Rectum WDNET 0.9/sm Many/+ Many/+++ Many/++
20 67 F Rectum WDNET 0.4/sm Many/+ Many/+++ Many/+++
21 56 M Rectum WDNET 1.0/sm Many/+++ Moderate/+++ Many/++
22 61 F Rectum WDNET 1.0/mp Many/+ Moderate/+++ Many/+++
23 44 M Rectum WDNET 0.6/sm Many/+++ Many/+++ Many/+++
24 36 M Rectum WDNET 0.8/mp Many/+ Moderate/++ Many/+++
25 64 F Duodenum WDNEC 3.0/mp Many/+ Many/+++ Many/+++
26 82 M Ileum WDNEC 2.4/mp Moderate/+ Many/+++ Many/++
27 74 F Appendix WDNEC 1.3/mp Many/+++ Moderate/++ Many/++
28 46 F Colon WDNEC 4.0/se Many/+++ Many/+++ Few/+
29 39 M Rectum WDNEC 1.8/sm Moderate/+++ Many/+++ Moderate/+++
30 61 M Rectum WDNEC 2.2/mp Many/+ Many/+++ Many/+++
M : male, F : female. WDNET : well differentiated NE tumor,
WDNEC : well differentiated NE carcinoma. sm : submucosa, mp : muscularis propria, se :
serosa. many : above 50%, moderate : between 5% and 50%, and few : below 5% of tumor cells.
+++,++,+,－ : strong, intermediate, faint, and negative, respectively.
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Fig.2．Schematic diagram of composite NEECs. Figures 2a-2c show the topological relationship of adenocarcinoma component
and NE components in the representative slide. Figures 2d and 2e show two exceptional composite NEECs in terms of NCAM
expression. M : mucosa, SM : submucosa, MP : muscularis propria and SE : serosa.
Fig.3．Composite NEEC (Case 1). Well differentiated adeno-
carcinoma component (right) and NE component (left) are lo-
cated side-by-side. The latter component is composed of small,
poorly differentiated cells with scanty cytoplasm.
Fig.4．Pure NE tumor (WDENET) of the stomach (Case 12).
Tumor is composed of trabeculae-like structures of small, round
cells with round-to-oval nuclei.
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3. Immunohistochemical findings in normal tissues
Normal superficial epithelial cells and crypts ad-
jacent to NE tumors showed no immunoreactivity for
NCAM. However, a few cells in deep glandswere posi-
tive for NCAM only in the stomach of the body and
antrum and the duodenumbut not in the intestine, co-
lon or rectum(Fig. 5a). TheseNCAM-immunoreactive
cells seemed to be not only NE cells but also non-NE
cells. A few ghrelin-immunoreactive cells were found
in normal deep glands of the stomach and duodenum
but not in the superficial epithelium (Fig. 5b). Strong
to intermediate immunoreactivity for Smad4 was
found in normal epithelium and crypts of the entire
GI tract. The immunostaining was completely disap-
peared after absorbing by the specific ghrelin antigen
and the tissue sections led to negative immunoreac-
tivity in the absence of NCAM and Smad4 antibodies.
4. Immunohistochemical findings in composite NEECs
Immunohistochemical findings of 8 composite
NEECs of the stomach are summarized in Table 3.
4.1. NCAM
In 5 (62.5%) of 8 composite NEECs, NEcomponents
showed immunoreactivity forNCAM,whichwasmostly
membranous (Table 4) (Fig. 6). The number and the
intensity of immunoreactive cells were varied from
case to case ; four cases showed immunoreactivity
in most tumor cells (Table 3). Out of these 5 NCAM-
positiveNE components, 3 cases (Cases 2, 5, 7) showed
homogeneous NCAM expression all over the areas.
Adenocarcinoma components of these 3 composite
NEECs showed no immunoreactivity for NCAM (Fig.
6). On the other hand, in the remaining 2 cases (Cases
1, 8) NCAM expression was different from the above
cases and unique. In Case 1, NCAMwas found homo-
geneously positive in one half area of NE component
and the other half contained only a fewNCAM-positive
cells (Fig. 2), although CgA was positive in all cells
of NE component. In CgA-negative adenocarcinoma
component of the same case, NCAM-immunoreactive
cells were occasionally found. In Case 8, CgA-positive
NE component showed NCAM immunoreactivity in
many cells and adenocarcinoma component showed
a heterogeneousNCAM immunoreactivity ; the larger
part of this tumor presented no immunoreactivity
Fig.5．a) Immunohistochemical expression of NCAM in normal
gastric mucosa. NCAM-positive cells are observed in deep glands.
b) Ghrelin in normal gastric mucosa. A substantial number of
ghrelin-positive cells are noted.
Table 3. Expression of NCAM, ghrelin and Smad４in composite NEEC
Case
No.
NCAM Ghrelin Smad4
NE comp.
Adenoca.
comp.
NE comp.
Adenoca.
comp.
NE
comp.
Adenoca.
comp.
1 Moderate/+* ± Many/+++ － Few/+ Many/++
2 Many/++** － Many/++ － Many/++ Many/++
3 － － － － － －
4 － － － － Few/+ Many/+
5 Many/+++＊＊ － － ± Many/+++ Many/+++
6 － － － － Many/++ Many/++
7 Many/++＊＊ － Few/+ ± Moderate/++ Moderate/++
8 Many/++＊ Moderate/++＊ Few/+ － Many/+ Few/+
9＊＊＊ Many/+++ － na na Many/+++ Many/+++
NE : neuroendocrine, adenoca : adenocarcinoma, comp : component.
Many : above 50%, moderate : between 5% and 50% and few : below 5% of tumor cells,
± : very few. +++, ++, +, － : strong, intermediate, faint, and negative, respectively
＊heterogeneous, ＊＊homogeneous, ＊＊＊composite NEEC of gallbladder. na : not available
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for NCAM,while a smaller part showed either partially
homogeneous or partially scattered immunoreactiv-
ity for NCAM(Fig. 2). In 3 of 8 composite NEECs, both
NE and adenocarcinoma components were negative
for NACM.
4. 2. Ghrelin
Ghrelin showed immunoreactivity in NE compo-
nents of 4 (50.0%) of 8 composite NEECs (Table 4)
(Fig. 7). The number of immunoreactive cells was
more than 50% of tumor cells in two cases (Cases 1, 2)
but a few in other two cases (Cases 7, 8). Adenocar-
cinoma components of 2 composite NEECs (Cases 5,
7) also showed immunoreactivity for ghrelin in a few
cells (Table 3) (Fig. 8).
4. 3. Smad4
Among 8 composite NEECs, 7 (87.5%) NE com-
ponents and respective adenocarcinoma components
Fig.6．NCAM in composite NEEC (Case5). Note that NCAM is
positive in NE component (below) and negative in adenocarcinoma
component (above).
Fig.7．Ghrelin in composite NEEC (Case1). Ghrelin is expressed
strongly in NE component (right) and negative in adenocarci-
noma component (left).
Table 4. Expression of NCAM, ghrelin and Smad4 in composite NEEC and pure NE tumor
Composite NEEC(8) Pure NE tumor(21)
NE comp. Adenoca. comp. WDNET(15) WDNEC(6)
NCAM
a Homogeneously positive 3(37.5%) 0 13(86.7%) 6(100.0%)
Positive in total 5(62.5%) 2(25.0%)＊ 13(86.7%) 6(100.0%)
Ghrelinb 4(50.0%) 2(25.0%)＊＊ 14(93.3%) 6(100.0%)
Smad4 7(87.5%) 7(87.5%) 15(100%) 6(100.0%)
NEEC : neuroendocrine-exocrine carcinoma, NE : neuroendocrine, Adenoca : adenocarcinoma,
comp : component, WDNET : well differentiated neuroendocrine tumor, WDNEC : well
differentiated neuroendocrine carcinoma.
＊ One of them showed immunoreactivity in a few tumor cells.
＊＊ Immunoreactivity in a few tumor cells.
a P <0.05, NE components of NEECs vs. pure NE tumors
b P <0.05, NE components of NEECs vs. pure NE tumors
Fig.8．Ghrelin in adenocarcinoma component of composite
NEEC (Case 5). Ghrelin is expressed in a few cells (arrows).
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showed immunoreactivity for Smad4 (Table 4). The
pattern of immunoreactivity for Smad4 was mostly
combined nuclear and cytoplasmic, which was same
as normal epithelium (Fig. 9).
5. Immunohistochemical findings in pure NE tumors
Immunohistochemical findings of 21 pure NE
tumors are summarized in Table 2.
5. 1. NCAM
NCAM immunoreactivity was found in 19 (90.5%)
of 21 pure NE tumors including 13 of 15WDNETs and
all 6 WDNECs (Table 2). The pattern of NCAM im-
munoreactivity was mainly membranous and in occa-
sionally cytoplasmic. NCAMpositive cells were evenly
distributed throughout the tumor tissue (homogene-
ous pattern). Among these 19 pureNE tumors, 78.9%
of cases showedNCAMimmunoreactivity inmore than
50% cells of each tumor (Fig. 10). No significant differ-
ence in NCAM immunoreactivity was found among
different anatomical sites.
5. 2. Ghrelin
Ghrelin immunoreactivity was found in all but one
(95.2%) of pure NE tumors of the GI tract including
14 of 15 WDNETs and all 6 WDNECs examined
(Table 2). The pattern of ghrelin immunoreactivity
was cytoplasmic (Fig. 11). Among these 20 pure NE
tumors, 65% of cases showed positive immunoreac-
tivity in more than 50% cells of each tumor (Fig. 11).
No significant difference in ghrelin immunoreactivity
was found among different anatomical sites.
5. 3. Smad4
All 21 pure NE tumors examined showed positivity
for Smad4 (Table 2).
6. Composite NEEC of the gallbladder
In the composite NEEC of the gallbladder (Case 9),
NE component occupied a vast majority of the tumor
and well differentiated adenocarcinomawas restricted
only in a small area of the mucosa of the gallbladder.
NE component invaded into the liver and occupied
the subtotal liver tissue. Immunohistochemically,NCAM
was strongly positive in most cells of NE component
while negative in adenocarcinoma component. Ghrelin
immunoreactivity was not examined due to the lack of
tissue. Smad4 showed a strong immunoreactivity both
in NE and adenocarcinoma components. Normal epi-
thelial tissue was negative for NCAM and ghrelin
(Table 3).
DISCUSSION
To our knowledge, therehasbeenno report ofNCAM
expression in composite NEECs of the gastrointes-
Fig.9．Smad4 in composite NEEC (Case5). Smad4 is positive in
both NE and adenocarcinoma components of the tumor.
Fig.11．Ghrelin in WDNET of the rectum (Case 24). Ghrelin
is moderately expressed in this WDNET.
Fig.10．NCAM in WDNET of the duodenum (Case 15). Many
tumor cells are immunoreactive for NCAM.
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tinal tract in English journals. In this study NE com-
ponents in 5 (62.5%) of 8 composite NEECs expressed
NCAM immunoreactivity either homogeneously (in
3 cases) or heterogeneously (in 2 cases). On the other
hand, almost all pure NE tumors expressed NCAM
immunoreactivity, which was homogeneously dem-
onstrated in most tumor cells. A significant difference
in homogeneousNCAMexpressionwasnotedbetween
NE components of composite NEECs and pureNE tu-
mors (37.5% and 90.5%, respectively, p<0.05), although
no significant difference inNCAMexpressionwas ob-
served among the anatomical tumor sites or between
histologic subtypes of pure NE tumors. It has been
well known that NCAM is an excellent marker for all
types of NE tumors including WDNETs (such as car-
cinoid tumors) and PDNECs (such as small cell car-
cinomas) of the lung (23-25), and thus the expression
of NCAM seems to be independent of the degree of
NE differentiation of tumors. Therefore, lower expres-
sion of NCAM inNE components of composite NEECs
is unlikely caused by poor differentiation of the tumors.
Among 5 composite NEECs with NCAM-positive
NE components, 3 tumors were uniformly positive for
NCAM in NE components and negative for NCAM in
adenocarcinoma components, showing a remarkable
difference between the two components and suggest-
ing a clonal expansion of the tumor cells with NE dif-
ferentiation.
It is noteworthy that NE components of 3 compos-
ite NEECs (Cases 3, 4, 6) were totally negative for
NCAMalthoughNEdifferentiationwasevidentbyCgA
immunoreactivity. This indicates that tumor cells in
these NE components may be different from those in
pure NE tumors of the GI tract in their NE property.
To the contrast, 2 composite NEECs (Cases 1and 8)
showed positive NCAMexpression in either scattered
or clustered cells of adenocarcinoma components.
These 2 tumors were also immunoreactive for NCAM
in NE components heterogeneously but not homo-
geneously. Of interest, in one case (Case 8) a few ade-
nocarcinoma components growing in a solid pattern
suggestive of NE differentiation showed a strong im-
munoreactivity for NCAM whereas the other parts
growing in a glandular or cord-like patternwere nega-
tive for NCAM. NCAM expression has been demon-
strated focally or heterogeneously in ordinary ade-
nocarcinomas arising in various sites including the GI
tract, lung, pancreas, breast and billiary tract (26-30).
The role of NCAM in such ordinary adenocarcinomas
is not known (29, 31). Nonetheless, several studies
suggested that 1) NCAM may appear in the earliest
stage of carcinoma (34), 2) these tumors may repre-
sent transition between non-NE tumor and NE tumor
(32), and 3) it may be non-specific likely in relation
with cross-reaction with an unidentified intracellular
glycoprotein present in mucinous adenocarcinoma
(33).
Ghrelin showed positive immunoreactivity in 95.2%
in pure NE tumors of the GI tract regardless of their
anatomic sites consistent with those reported previ-
ously. Pappoti et al . showed that 75% of gastric NE
tumors and 27% of intestinal NE tumors were im-
munoreactive for ghrelin (17). Rindi et al. also reported
that ghrelin-immunoreactivity was seen in 76% of well
differentiated gastric NE tumors although they did not
find ghrelin-immunoreactive cells in intestinal NE
tumors (16). The two studies used anti-ghrelin anti-
body that recognized the mid- to C-terminal of ghrelin
(13-28 sequence) and we also used the antibody that
recognized mid-portion of ghrelin. In our preliminary
study using another anti-ghrelin antibody that recog-
nized the N-terminal of ghrelin, only 21.7% of the pure
NE tumors showed ghrelin immunoreactivity (data
not shown). It is of note that there would be a great
difference in ghrelin immunoreactivity in NE tumors
depending on the type of antibody used.
There has been no report on ghrelin immunoreac-
tivity in gastric composite NEECs so far. Our study
revealed that ghrelin was positive in 4 of 8 NE com-
ponents and 2 adenocarcinoma components and only
a small number of positive cells were noted in 2NEcom-
ponents and 2 adenocarcinoma components among
ghrelin-positive tumors. A significantly lower incidence
of ghrelin immunoreactivity in gastric compositeNEECs
than pure NE tumors (50.0% vs. 95.2%, p<0.05) may
be partly due to the difference in NE differentiation.
Rindi et al. reported that ghrelin immunoreactivity was
not seen in poorly differentiatedNE tumors of the stom-
ach (16).
Smad4 showed positive immunoreactivity in 87.5%
of NE and adenocarcinoma components of compos-
ite NEECs and in all pure NE tumors examined. Thus,
Smad4 showed no significant difference in expression
between composite NEECs and pureNE tumors. Smad4
has been known to be involved in the tumorigenesis
of exocrine tumors such as pancreatic, gastric and col-
orectal adenocarcinomas as one of tumor suppressor
genes (18, 19). On the other hand, the role of Smad4
on NE tumors is yet to be clarified. In previous stud-
ies, Smad4 expression was found inNE tumors of the
GI tract, pancreas and extrahepatic bile duct (20 -22,
34). Two recent studies on NE tumors of pancreas
showed different expression of Smad4. One study by
Bartsch et al. showed that Smad4 mutation and ho-
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mozygous deletions were observed in 55% of NE tu-
mors of pancreas (35), whereas Smad4 inactivation
by mutation or deletion was very rare in the second
study by Perren et al. (20). The present immunohis-
tochemical study implies that the role of Smad4 on
tumorigenesis may beminimum for both gastric com-
posite NEECs and pure NE tumors of GI tract.
It has been claimed that the tumorigenesis of pure
NE tumors, especially of well differentiated type, and
that of NE components of composite NEECs are dif-
ferent to each other. Most pureNE tumorsmay origi-
nate from the cell foredoomed to differentiate to NE
cell (7, 36). On the other hand, as for the histogenesis
of composite NEECs there are two known hypothe-
sis : 1) simultaneous proliferation of different lines
of cells, non-NE cells and NE cells, and 2) prolifera-
tion of pluripotent precursor cells capable of differ-
entiation along adenocarcinomas or NE tumors (8-
11, 37-39). In our study, the presence of transitional
zone argues against of a collision tumor of our cases.
The topographical relationship of the two components
within a composite NEEC may be an indicative point
of the histogenesis of the tumor. The two components
are likely to be influenced by both temporal relation-
ship and growth potential of dual differentiation (40).
In the present study, most of composite NEECswere
composed of superficially located, smaller, well differ-
entiated adenocarcinoma component and juxtaposed,
larger NE component at the deeper part of the tumor.
Transitional zone between the two components was
observed practically in all our cases although not promi-
nent. These findings are consistent with previous stud-
ies showing that the adenocarcinoma components
were mostly located in the mucosa and submucosa
and that the NE components were in the deeper part
of the gastric wall (6, 10, 40-42). In addition, Kim et al.
performed a genetic study of gastric composite NEECs
and found that 6 of 8 cases showed a primary loss of
heterozygosity which was shared by both adenocar-
cinoma and NE components and a secondary loss of
heterozygosity or mutation that were restricted inNE
components, irrespective of the tumor size (40). They
suggested that most of gastric composite NEECswere
sequentially evolved from a glandular precursor to a
genetically heterogeneous adenocarcinoma and then
to NE carcinoma (40). The morphological and immu-
nohistochemical findings in our study also suggest that
NE components in 6 of 8 gastric composite NEECs
may develop from a precursor cell of the early-stage
adenocarcinoma and subsequently show a clonal ex-
pansion of NE tumor cells resulting in a mass iden-
tifiable as NE carcinoma. This hypothesis may be ap-
plied not only to composite NEECs of the stomach but
also to those of other organs, because similar histo-
logical and immunohistochemical findings were ob-
served in a case arising in the gallbladder (Case 9).
The remaining two cases of gastric compositeNEECs
reported by Kim et al. reciprocally lost different allele
of identical loci on multiple chromosomes, suggesting
a dual differentiation concurrently arising from a single
precursor (40). Similarly, in our two cases (Cases 1
and 8), smaller NE components were found hetero-
geneously within the adenocarcinoma components
and side-by-side, suggesting that these components
may be from a pluripotent epithelial cell. Similar hy-
pothesis was also proposed by Vortmeyer et al., who
suggested that poorly differentiated colorectal NE car-
cinomas associated with adenocarcinomasweremost
likely derived from either a pluripotent epithelial stem
cell or an adenocarcinoma precursor cell (43).
In summary, the present morphological and immu-
nohistochemical study, taken together with the pre-
vious findings, indicates that NE components of com-
posite NEECs may have different NE property and tu-
morigenesis from pureNE tumors and thatmost com-
posite NEECs may originate from an adenocarcinoma
precursor cell while occasional tumors from a pluri-
potent epithelial cell. NCAM may have some role in
NE differentiation in more than half of NE components
of NEECs.We believe that better description and iden-
tification of composite NEECs may lead to better rec-
ognition of distinct clinical behavior of NE tumors aris-
ing in the GI tract.
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